Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 18, Issue 17, 2012, Pages 2005-2008

  Ishikawa, Toru ^a  

^a Saiseikai Niigata Daini Hospital   (Japan)

Author keywords

Branched chain amino acids to tyrosine ratio; Fischer's ratio; Hepatocellular carcinoma; Prognostic factor

Indexed keywords

BRANCHED CHAIN AMINO ACID; TYROSINE;

AMINO ACID METABOLISM; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CHRONIC LIVER DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; LIVER BLOOD FLOW; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER METABOLISM; NONHUMAN;

EID: 84860587732     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v18.i17.2005     Document Type: Article

References (16)

1. Okuda K. Hepatocellular carcinoma. J Hepatol 2000; 32: 225-237
2. Shiratori Y, Yoshida H, Omata M. Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention. Expert Rev Anticancer Ther 2001; 1: 277-290
3. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649
4. Morgan MY, Marshall AW, Milsom JP, Sherlock S. Plasma amino-acid patterns in liver disease. Gut 1982; 23: 362-370
5. Soeters PB, Fischer JE. Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet 1976; 2: 880-882
6. Azuma Y, Maekawa M, Kuwabara Y, Nakajima T, Taniguchi K, Kanno T. Determination of branched-chain amino acids and tyrosine in serum of patients with various hepatic diseases, and its clinical usefulness. Clin Chem 1989; 35: 1399-1403
7. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 1968; 64: 134-142
8. Suzuki K, Suzuki K, Koizumi K, Ichimura H, Oka S, Takada H, Kuwayama H. Measurement of serum branched-chain amino acids to tyrosine ratio level is useful in a prediction of a change of serum albumin level in chronic liver disease. Hepatol Res 2008; 38: 267-272
9. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-713
10. Nagasue N, Kanashima R, Inokuchi K. Alteration in plasma amino acid concentrations following subtotal hepatectomy in dogs. Ann Chir Gynaecol 1981; 70: 50-55
11. Nagasue N, Yukaya H, Sasaki Y, Ogawa Y, Hirose S. Infusion of branched chain amino acids after partial hepatectomy in man. Nutr Cancer 1984; 6: 32-39
12. Joyeux H, Matias J, Saint-Aubert B, Astre C, Gouttebel MC, Vedrenne JB, Deneux L. [Serum marker of the functional hepatic mass after extensive hepatectomy. The branched/aromatic amino acid ratio. Experimental and clinical studies]. Chirurgie 1994; 120: 283-288
13. Niguma T, Yumura M, Yamasita Y, Maeda K, Kimura T, Yamamura M, Kodani J. Ratio of branched chain amino acid to tyrosine after hepatectomy. Surg Today 1999; 29: 825-827
14. Ozawa K, Aoyama H, Yasuda K, Shimahara Y, Nakatani T, Tanaka J, Yamamoto M, Kamiyama Y, Tobe T. Metabolic abnormalities associated with postoperative organ failure. A redox theory. Arch Surg 1983; 118: 1245-1251
15. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976; 80: 77-91
16. Shimizu H, Taniguchi K, Sugiyama M, Kanno T. Rapid enzymatic analysis of plasma for tyrosine. Clin Chem 1990; 36: 32-35